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COVID-19 is continuing to take its toll, with the expected second 
peak across Europe and in parts of the USA now well established and 
concentrating the minds of politicians around restrictive measures 
in an effort to control what is seen as the inevitable toll of illness 
and death that will result. However, for a virus that was unknown to 
science until roughly 10 months ago, we have learnt a lot about SARS-
CoV-2. Pure observation shows that the virus is particularly deadly in 
the elderly and in those, even in younger age groups, who have at least 
one associated comorbidity. The comorbidities that crop up most 
frequently as indicators of risk are type 2 diabetes and hypertension. 
Obesity has also been shown to be a major independent risk factor, 
and of course predisposes to other comorbidities. I have, cynically, 
often wondered that if the virus had arisen somewhere in Africa, like 
Ebola, and not had such a devastating effect on Western populations, 
the global response would have been as extreme as it is. And it would 
appear that there are good underlying reasons for the concentration 
of adverse effects in many Western countries, quite apart from the 
obvious factor of ageing populations. The Global Burden of Disease, 
Injuries and Risk Factors Study (GBD) 2019 has just been published 
in the Lancet[1] and, in the words of a Guardian Online[2] article, 
shows that ‘The failure of governments to tackle a three-decade rise 
in preventable diseases such as obesity and type 2 diabetes has fuelled 
the COVID-19 pandemic and is stalling life expectancy around the 
world …’. Indeed, the editor of the Lancet, Richard Horton, goes so 
far as to say that COVID-19 is not a single pandemic, but ‘a synthesis 
of a coronavirus and an epidemic of non-communicable diseases on 
a background of poverty and inequality’. 
The Guardian Online article pulls out selected countries in Western 
Europe, showing that the UK in particular not only has a lower 
overall life expectancy than countries such as Iceland, Switzerland, 
Italy and Norway, but also has a healthy life expectancy of only 68.9 
years – a good way behind the other countries selected. This gap, 
suggesting, even in those countries with better metrics than the UK, 
at least 10 years of poor-quality life before death, is pretty damning in 
itself. But that is for another day. 
The upshot of the GBD study is that more people worldwide are 
experiencing high blood pressure and diabetes, and are overweight or 
obese. There is also a rising tide of cardiovascular disease, particularly 
in the USA and the Caribbean. And if you look at the countries in 
the developing world most affected by COVID-19, they are in South 
and Central America and in Africa, where the major burdens are in 
South Africa (SA), Algeria and Egypt. Given the striking variation 
in morbidity and mortality apparent between younger and older age 
groups, these three African countries might be expected to be more 
severely affected by COVID-19. The proportion of the population 
aged >65 in South Africa is 5.4%, in Algeria it is 7% and in Egypt it 
is 5%.[3] However, there are multifactorial risk factors associated with 
poor outcomes in COVID-19, and age is only one of them. While it 
is undeniable that communicable diseases such as tuberculosis and 
HIV still account for a very high proportion of deaths and disability 
in SA, along with trauma, our burden of non-communicable diseases 
is undoubtedly also rising. Indeed, Bradshaw et al.[4] show that in 
the period 1985 - 2012, non-communicable diseases accounted for 
high proportions of deaths in whites and Indians/Asians. Although 
the proportion of deaths from non-communicable diseases in black 
Africans was arrested by the HIV/AIDS epidemic, the proportion 
started to increase again from 2005, leading to our so-called 
quadruple burden of disease. 
It is too soon to start to draw definitive conclusions about why 
SA has dominated the numbers across Africa, lack of data elsewhere 
because of lack of testing and questionable record-keeping aside. 
However, I remember watching the pandemic unfolding in Europe 
and then in the USA before it hit Africa and thinking that because 
of our more westernised conditions in SA, we were likely to have 
a bad time of it. Add the burden of poverty and one of the most 
unequal societies in the world, and what has happened here is far 
from surprising. This virus has torn aside any hopes we might have 
continued to harbour of firm infrastructure and economic resilience 
and highlighted our acute vulnerability to such major shocks. It is 
only the competence, dedication and sheer brilliance of our medical 
community, doctors and nurses, that prevented us from seeing the 
kinds of sights that greeted the people 
of New York and northern Italy early in 
the pandemic. We now need to use these 
lessons to tackle all areas of vulnerability, 
disease specific and socioeconomic, and 
take something positive out of what has 
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